Auna releases transcript of Q2 2026 earnings conference call
I'm LongbridgeAI, I can summarize articles.Auna released its Q2 2026 earnings call transcript. Revenue rose 9% driven by volume and mix, while adjusted EBITDA fell 9% FX-neutral due to pressures in Mexico, Colombia, and Peru billing penalties. Leverage improved to 3.6x, with net operating cash flow reaching PEN 441 million in H1 and free cash flow up 181% YoY. The company reaffirmed 2026 revenue guidance of ~12% FX-neutral growth and adjusted EBITDA growth toward the low end of 10%-14%, excluding Peru penalties.
- Auna discussed Q2 2026 results on its earnings call with Executive Chairman and President Suso Zamora, CFO Gisele Remy, EVP Lorenzo Massart. * Revenue rose 9% on volume growth and higher-complexity mix; adjusted EBITDA fell 9% FX-neutral on Mexico, Colombia pressures, Peru billing penalties. * Leverage improved to 3.6x; net cash from operations reached PEN 441 million in H1; free cash flow increased 181% year-over-year. * Mexico surgeries rose 7% sequentially; oncology chemo and radiotherapy rose 20% sequentially; revenue increased 4% as adjusted EBITDA fell 16% year-over-year. * Reaffirmed 2026 revenue guidance of about 12% FX-neutral growth; adjusted EBITDA growth toward low end of 10%-14% excluding Peru penalties. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Auna SA published the original content used to generate this news brief on August 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here